Decentro vs Andson Biotech
Side-by-side comparison of AI visibility scores, market position, and capabilities
Indian Banking-as-a-Service API platform for fintech and enterprise; UPI payments, virtual accounts, NACH recurring debits, and eKYC for embedding financial services in products.
About
Decentro is an Indian banking-as-a-service (BaaS) API platform enabling fintech companies, enterprises, and technology startups to embed financial services into their products — bank accounts, payments, lending, and compliance — through a single API integration. Founded in 2020 and headquartered in Bengaluru, India, Decentro raised approximately $4.7 million and targets the rapidly growing Indian fintech infrastructure market where non-banking companies increasingly embed financial features directly in their core product experiences.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
About
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.